SITC 2026 — 41st Annual Meeting of the Society for Immunotherapy of Cancer
4 Nov 2026 – 8 Nov 2026 · Phoenix Convention Center, Phoenix, AZ, USA · In-Person
SITC 2026 is the world's leading meeting dedicated to cancer immunotherapy, bringing together researchers, clinicians, industry leaders and early-career scientists to advance the science, discover breakthroughs and educate the world on cancer immunotherapy.
Who Attends
- Researchers share their latest work with cancer immunotherapy leaders
- Clinicians learn how the latest immuno-oncology science can better treat their patients
- Industry networks with international leaders from academia and government
- Early Career Scientists meet established leaders in the field through dedicated activities, including the Undergrads in STEM program
Program Highlights
The meeting features a full scientific schedule with oral and poster abstract presentations, late-breaking abstracts, industry presentations, sponsored symposia and Tech Talks, plus career development through Career Connections and the popular CheckPoints Party networking event. Continuing education credits are offered, with enduring materials available after the meeting.
Abstracts
Abstract submission is open with published guidelines, categories and selection policies, including dedicated Early Career Investigator Award abstracts and late-breaking abstract tracks. Important dates and presenter guidelines are published on the meeting website.
Support and Exhibition
SITC 2026 is supported by a broad group of corporate supporters, with exhibit, sponsorship and advertising opportunities detailed in the exhibitor section, including floor plans and booth reservation.
Registration rates, housing and visa information are available on the official meeting website.
Source: official meeting website (sitcancer.org/2026).
